Hypothyroidism is characterized by a high thyroid stimulating hormone (TSH) level and low thyroid hormones (T3 and/or T4). Abnormalities in ovulation, infertility, and recurrent pregnancy losses can arouse due to hypothyroidism. Pregnancy is a physiological status that mandates an increase in levothyroxine doses for euthyroid women with primary hypothyroidism. Serum levels of thyroid stimulating hormone can increase significantly during In-Vitro fertilization among women treated for hypothyroidism, and hypothyroidism that is either undiagnosed or under-treated can contribute to infertility and result in miscarriages. Throughout the literature, artificial pregnancies, In-Vitro fertilization (IVF) mainly, have required a more aggressive increase in the levothyroxine dose. Here, we report the case of a 40-year old hypothyroid woman with a history of nine abortions after IVF procedures who presented for treatment of her hypothyroidism. We present in details the modification process of her levothyroxine dose according to monthly TSH levels starting from her ninth miscarriage through her tenth IVF procedure and all throughout the pregnancy, until the successful delivery of a healthy baby.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.